Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples. - Wikidata - awgldk - TriplyDB

Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.

Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.

http://www.wikidata.org/entity/Q34014559

about

sameAs

RASSF tumor suppressor gene family: biological functions and regulation Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection Methylated DNA as Promising Marker for Early Diagnosis of Cancer Galectin-3: a potential target for cancer prevention.Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MS.MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer.Galectin-3 as a Potential Target to Prevent Cancer Metastasis.Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.CLINICAL EVALUATION OF AN EPIGENETIC ASSAY TO PREDICT MISSED CANCER IN PROSTATE BIOPSY SPECIMENS.MIEN1 is tightly regulated by SINE Alu methylation in its promoter.Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.The epigenetic promise for prostate cancer diagnosis.The cellular functions of RASSF1A and its inactivation in prostate cancer.Toward the detection of prostate cancer in urine: a critical analysis.Global DNA hypomethylation in prostate cancer development and progression: a systematic review.The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages.Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, α9 nicotinic acetylcholine receptor and STAT3.The noninvasive detection of RARβ2 promoter methylation for the diagnosis of prostate cancer.Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer.Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.Epigenetic risk score improves prostate cancer risk assessment.Aberrant promoter methylation of the cadherin 13 gene in serum and its relationship with clinicopathological features of prostate cancer.GCPII modulates oxidative stress and prostate cancer susceptibility through changes in methylation of RASSF1, BNIP3, GSTP1 and Ec-SOD.Long Non-Coding RNAs Serve as Diagnostic Biomarkers of Preeclampsia and Modulate Migration and Invasiveness of Trophoblast Cells.Functions of galectins as 'self/non-self'-recognition and effector factors.Developing DNA methylation-based diagnostic biomarkers.

P2860

Q26866080-D7FF27D3-98D3-4521-B247-F6AF41B6D465 Q30570945-068C661E-A4B4-4760-801A-2D42770A2EC6 Q33838513-CF646038-0E04-49B8-B045-E85F12814E31 Q34294196-C25215A2-CBFA-4476-9535-02438F9E6A19 Q34539679-674DDBF7-77FC-43C4-B90D-E37775BECEE3 Q34626339-F514C49F-D64A-4896-A045-420229E9FCB0 Q34633152-5C8088FE-7927-43BD-8679-E1A75D4183E5 Q35033878-8FBB9EA2-B49B-4382-9790-54D7C77B2190 Q35163033-AD00747B-1F61-464D-8BDB-66230EC499FC Q36326176-FD136102-91B0-425E-8D12-220E20A9D695 Q37059172-B2D50E69-4C68-4F22-A3C8-E1C64DB5015F Q37563750-B9DF69C3-76EB-4A2B-987F-F75CFD37914E Q37662226-FCE1457A-78DE-4347-A67A-27B9058AF899 Q37878470-4437FFE7-E8E8-4904-A833-4625E2D89D4B Q37967574-EDBE91F7-DF07-4396-B111-74BDC9ED2F12 Q37996013-5C8662BC-9A0E-4674-A17F-3072A920CA06 Q38047103-C6D9A850-95BD-4524-906B-47A676D8D774 Q38266607-59E74A98-06CF-4D81-BF9D-39FC0A5537E1 Q38269155-437C13B8-DB7E-46E9-A1C6-1658B5F4B0F5 Q38758852-1A254CDD-CCA4-4D90-B868-BD04EF6F6BAC Q38904571-283C6816-AFE3-435C-89A8-366B201B3AA9 Q38913306-DA8B412D-FD2E-4B97-B3D2-7BDA6A076896 Q39011785-0FF9FBDA-4ABE-4B99-8E63-C091CFD00A3F Q39114439-400C2289-14A6-4DD7-9552-EF9B13CF6377 Q39118557-8BE6ED03-A7EF-4344-A399-99AF1FA9A680 Q40848507-FF373816-7617-442A-9873-1823C3A8E104 Q40985522-293865A6-65A1-4800-8E1B-8DF213F9180A Q43152996-DC88F4E7-17B5-466F-A39C-201567F1128C Q44528110-1C26C62D-23E3-4523-AD21-A9039CC878F5 Q47694192-325785E3-1B67-408A-80E9-428194F9CB93 Q49917325-CCE6ADB4-614C-40D0-B2F4-5857FD28DD23 Q51031908-079E14A1-3AE6-4BF4-92EE-ECD1136D0AC5 Q52370391-9A30154A-3E31-4AAF-A1D3-1D5FB170F468

P2860

Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.

http://www.wikidata.org/entity/Q34014559

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@ast

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@en

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@nl

type

label

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@ast

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@en

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@nl

altLabel

Promoter methylation in prosta ...... using serum and urine samples

@en

Promoter methylation in prosta ...... using serum and urine samples

@nl

prefLabel

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@ast

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@en

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@nl

P1433

Q34014559-06E8CA6C-B5C2-4CE0-B06D-85C85E6C6443

P1476

Q34014559-9CAA8089-6A4F-4CA6-8B53-876C002274FD

Q34014559-DCFF0B55-03D8-4A4D-91FA-9D6639C8973F

P2093

Q34014559-3EA38070-CBB6-486C-8B0C-70F806344A82

P2860

Q34014559-011F7F35-D7EA-4017-AB95-50810B2F7B03

Q34014559-016DF309-ACAB-4B67-9E15-A9C47B36454A

Q34014559-02B205D6-8CBE-493B-BDF2-C87CE2D249DE

Q34014559-062EB12C-8805-4D87-B6DA-889CEA41DC0F

Q34014559-0810D7A0-175E-40B2-96DF-D1EB1FE6B9DF

Q34014559-083B6029-7265-4693-9896-CF7ACE3E9A5E

Q34014559-08BBCD96-F0C9-4DBA-A059-AA5FB1063159

Q34014559-0BDF4EDB-B65B-4036-8B80-82FA11305123

Q34014559-0E813ED0-6E40-41EA-8DBB-09371A5DFB6A

Q34014559-0F35EBB6-8791-4C95-8BF3-EFC1D0BFAE93

P304

Q34014559-BC04561D-52A8-4AD4-998F-58A09C97007A

P31

Q34014559-106A98E6-855F-4CC9-AE50-8A8D5B604440

P356

Q34014559-DF98F1CF-F30F-4BFB-9162-D7693F0CD60D

P407

Q34014559-075A0360-D37F-4F68-BB82-85242391CAD5

P433

Q34014559-5010C3EA-11AF-4B50-8A60-6D703EEB9114

P478

Q34014559-407BB2DF-BDC8-4E58-9978-9D176B02FDBC

Q34014559-DF983BC3-5D3A-4AAF-BEA0-15A55BFA3D50

P577

Q34014559-4E0D6173-39D9-4A94-83B3-91D0FE334DCC

Q34014559-D71EA3C3-9D12-4BC4-B8AD-B4B61851EAA0

P698

Q34014559-519FADBA-BC15-4D50-8D97-993E2B1E90D5

Q34014559-6D0F9D07-E466-4E58-A334-10E61D03100E

P932

Q34014559-A2AC2B89-74CC-447E-90A0-B038B13E2AA7

P356

P1433

Biomarkers in cancer

P1476

Promoter Methylation in Prosta ...... Using Serum and Urine Samples.

@en

Promoter methylation in prosta ...... using serum and urine samples

@en

P2093

Hafiz Ahmed

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation

Identification and characterization of a family of mammalian methyl-CpG binding proteins

The Hallmarks of Cancer

The Ski protein family is required for MeCP2-mediated transcriptional repression

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex

ER beta: identification and characterization of a novel human estrogen receptor

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer

Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer

P304

17-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/BIC.S3187

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

2010

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2010-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20657713

http://www.w3.org/2001/XMLSchema#string

24179382

http://www.w3.org/2001/XMLSchema#string

P932

2908742

http://www.w3.org/2001/XMLSchema#string